Peter Cresswell

3.9k total citations · 1 hit paper
22 papers, 3.4k citations indexed

About

Peter Cresswell is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter Cresswell has authored 22 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 7 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter Cresswell's work include Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (6 papers). Peter Cresswell is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (6 papers). Peter Cresswell collaborates with scholars based in United States, Australia and South Africa. Peter Cresswell's co-authors include Paul J. Lehner, Thomas A. Spies, Eric Hughes, Bodo Ortmann, Bhanu Sadasivan, Karen S. Anderson, Matthew J. Androlewicz, John Newcomb, Michael S. Marks and Janice M. Riberdy and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Peter Cresswell

21 papers receiving 3.3k citations

Hit Papers

Roles for Calreticulin and a Novel Glycoprotein, Tapasin,... 1996 2026 2006 2016 1996 100 200 300 400 500

Peers

Peter Cresswell
Judy Bastin United Kingdom
Mary T. Crowley United States
Rachel M. Gerstein United States
Lonnie Lybarger United States
Frédéric Lévy Switzerland
F. Nina Papavasiliou United States
Peter Cresswell
Citations per year, relative to Peter Cresswell Peter Cresswell (= 1×) peers Matthew J. Androlewicz

Countries citing papers authored by Peter Cresswell

Since Specialization
Citations

This map shows the geographic impact of Peter Cresswell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Cresswell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Cresswell more than expected).

Fields of papers citing papers by Peter Cresswell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Cresswell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Cresswell. The network helps show where Peter Cresswell may publish in the future.

Co-authorship network of co-authors of Peter Cresswell

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Cresswell. A scholar is included among the top collaborators of Peter Cresswell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Cresswell. Peter Cresswell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brahma, S. K., et al.. (2025). CD1diNKT Axis in Infectious Diseases: Lessons Learned From the Past. Scandinavian Journal of Immunology. 101(4). e70024–e70024.
2.
Tomazin, Roman, Jessica M. Boname, Nagendra R. Hegde, et al.. (1999). Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nature Medicine. 5(9). 1039–1043. 222 indexed citations
3.
Peh, Chen Au, Scott R. Burrows, Megan Barnden, et al.. (1998). HLA-B27–Restricted Antigen Presentation in the Absence of Tapasin Reveals Polymorphism in Mechanisms of HLA Class I Peptide Loading. Immunity. 8(5). 531–542. 224 indexed citations
4.
Hughes, Eric & Peter Cresswell. (1998). The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex. Current Biology. 8(12). 709–713. 162 indexed citations
5.
Lehner, Paul J., et al.. (1998). Soluble Tapasin Restores MHC Class I Expression and Function in the Tapasin-Negative Cell Line .220. Immunity. 8(2). 221–231. 255 indexed citations
6.
Cresswell, Peter & Eric Hughes. (1997). Protein degradation: The ins and outs of the matter. Current Biology. 7(9). R552–R555. 30 indexed citations
7.
Grandea, Andres G., Paul J. Lehner, Peter Cresswell, & Thomas A. Spies. (1997). Regulation of MHC class I heterodimer stability and interaction with TAP by tapasin. Immunogenetics. 46(6). 477–483. 78 indexed citations
8.
Cresswell, Peter. (1996). Invariant Chain Structure and MHC Class II Function. Cell. 84(4). 505–507. 284 indexed citations
9.
Hammond, Craig, et al.. (1996). Trafficking of major histocompatibility complex class II molecules through intracellular compartments containing HLA-DM. Human Immunology. 45(1). 13–23. 22 indexed citations
10.
Sadasivan, Bhanu, Paul J. Lehner, Bodo Ortmann, Thomas A. Spies, & Peter Cresswell. (1996). Roles for Calreticulin and a Novel Glycoprotein, Tapasin, in the Interaction of MHC Class I Molecules with TAP. Immunity. 5(2). 103–114. 574 indexed citations breakdown →
11.
Storkus, Walter J., Maria L. Wei, Peter Cresswell, & Jeffrey R. Dawson. (1996). Class I-like CD1A-C Do Not Protect Target Cells from NK-Mediated Cytolysis. Cellular Immunology. 167(1). 154–156. 6 indexed citations
12.
Cresswell, Peter. (1994). Antigen Presentation: Getting peptides into MHC class II molecules. Current Biology. 4(6). 541–543. 50 indexed citations
13.
Cresswell, Peter, et al.. (1994). In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity. 1(9). 763–774. 164 indexed citations
14.
Arnold, Danièle, James J. Driscoll, Matthew J. Androlewicz, et al.. (1992). Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules. Nature. 360(6400). 171–174. 188 indexed citations
15.
Riberdy, Janice M., et al.. (1992). HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature. 360(6403). 474–477. 318 indexed citations
16.
Anderson, Karen S., Peter Cresswell, M T Gammon, et al.. (1991). Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis.. The Journal of Experimental Medicine. 174(2). 489–492. 190 indexed citations
17.
Storkus, Walter J., Russell D. Salter, J. J. Alexander, et al.. (1991). Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.. Proceedings of the National Academy of Sciences. 88(14). 5989–5992. 109 indexed citations
18.
Marks, Michael S. & Peter Cresswell. (1986). Invariant chain associates with HLA class II antigens via its extracytoplasmic region.. The Journal of Immunology. 136(7). 2519–2525. 16 indexed citations
19.
Marks, Michael S. & Peter Cresswell. (1985). Invariant chain associates with HLA class II antigens via its extra-cytoplasmic region. Human Immunology. 14(2). 138–138. 25 indexed citations
20.
Machamer, Carolyn E. & Peter Cresswell. (1984). Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex.. Proceedings of the National Academy of Sciences. 81(5). 1287–1291. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026